Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CTSL -- Ignore unavailable to you. Want to Upgrade?

To: dlc who wrote (1217)	12/24/1998 8:20:00 AM
From: wolfdog2	Read Replies (1) \| Respond to of 1354

dlc, I'm sorry you had such a bad experience with CTSL. If you use it as a source of ideas that need to be tested, I think you might find the service useful. I certainly do. Lately, MM has been very right on the direction of PC sales (up) and got you and any other subscriber who listened got into the group early. His worst errors come from (1) not cutting his losses, but you can cut yours when he picks a bummer; and (2) trying to catch falling knives. You don't have to follow him into these and can watch until they do form bottoms.

To: dlc who wrote (1217)	12/24/1998 1:47:00 PM
From: BelowTheCrowd	Read Replies (1) \| Respond to of 1354

Simple fact, which Murphy unfortunatley understates: If you invest in small or mid-cap biotech, you are likely to lose your shirt on some investments. Every venture capitalist in the valley knows it, as do virtually all the biotech funds. The only way to play this is with a well diversified portfolio, knowing full well that out of 10, 4-5 will probably fail, 1 will be a home run, 1-2 will do OK and the rest will just languish roughly forever. If you can't do that, you probably shouldn't be in those kinds of stocks, and it doesn't matter if you follow Murphy's picks, McCamants picks, or anybody elses. A friend of mine is the biotech analyst at Robertson Stephens. His favorite phrase: "Biotech is a graveyard for most companies." mg